Vivos Therapeutics Reports Significant Revenue Growth During the Third Quarter 2025

Financial results highlighted by 78% sequential quarter over quarter revenue growth, showing the impact of the first full quarter of Sleep Center of Nevada operations

Read more at globenewswire.com